NEW YORK (GenomeWeb) – DiaCarta today announced it raised $8 million in a Series A financing round. 

Proceeds will go toward commercialization of its products and the expansion of its portfolio, it said, adding the financing came from BioVeda China Fund. In conjunction with BVCF's financing, Weixin Xu, a principal at the venture capital fund, will join DiaCarta's board.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.